Pharmaceutical products market in Norway: size, suppliers and public contracts
Market size and key facts
In 2025, public buyers in Norway awarded 79 supply contracts for pharmaceutical products through award notices on TED; the 37 of them that state a value (46.8%) add up to €45.9 million, a floor rather than the full contract value.
- Since November 2023, 57 companies have won 134 public supply contracts for pharmaceutical products in Norway, in 63 award notices from 34 public buyers.
- 70.1% of these awards went to companies registered in Norway; the most frequent foreign origin is Denmark.
- The five companies that win most often hold 30.6% of all awards.
- 35.7% of the awards whose notice states the number of tenders received a single bid.
In proportion
All public purchasing in Norway — general government spending on goods, services and investment, the measure the OECD and the European Commission use for public procurement — came to €69.3 billion in 2025, 14.7% of GDP (Eurostat). Award notices on TED cover only the contracts above the EU thresholds, so they show who wins, not the whole of that spending.
General government spending on goods, services and investment for health in Norway came to €16 billion in 2024 (Eurostat, COFOG). How much of it reaches suppliers through tenders depends on how the country organises the sector — for example whether statutory health insurance is classified in government.
Source: Eurostat, government finance statistics (gov_10a_main, gov_10a_exp) and GDP (nama_10_gdp), retrieved 9 November 2026.
Updated · counted daily from contract award notices on TED and Eurostat international trade data · figures as JSON · free to quote with attribution (CC BY 4.0)
How to cite: Cresques, "Pharmaceutical products market in Norway", https://cresques.com/markets/no/336-pharmaceutical-products, from TED contract award notices (© European Union) and Eurostat Comext, updated 13 November 2026. Licence: CC BY 4.0.
What industry and official reports say
- EFPIA puts the European pharmaceutical market at €302 billion at ex-factory prices in 2024, with €330 billion estimated for 2025. EFPIA, The Pharmaceutical Industry in Figures – Key Data 2026
- Medicines for Europe reports that generic medicines account for 70% of treatment volume in Europe (2023). Medicines for Europe, Press release: Generic medicines: 70% of dispensed medicines and critical to healthcare
- Eurostat puts current healthcare expenditure in the EU at €1,720 billion in 2023, 10.0% of GDP; medical goods took 17.8% of it. Eurostat, Healthcare expenditure statistics - overview (Statistics Explained)
Figures from the publishers named, checked at the source on 9 November 2026. They measure the whole market (all buyers, different price bases and country scopes), so they are not comparable one-to-one with the public contract counts on this page.
- Winning companies
- 57
- since November 2023
- Award notices
- 63
- on TED
- Public buyers
- 34
- hospitals, schools, agencies
- Imports
- —
- no customs heading isolates this category
The market in numbers
Public supply contracts in Norway: award notices published on TED from 2023-11 to 2026-11, by publication year.
- Contracts awarded
- 134
- in 63 award notices
- Awarded value
- €55.1M
- from 34% of awards with a published value
- Winning companies
- 57
- with at least one award
- Public buyers
- 34
- hospitals, cities, agencies
Table view
| Nov–Dec 2023 | 1 |
| 2024 | 38 |
| 2025 | 79 |
| 2026 | 16 |
Table view
| Nov–Dec 2023 | €0 |
| 2024 | €4.6M |
| 2025 | €45.9M |
| 2026 | €4.6M |
Table view
| Hospitals and health services | 88 |
| Cities, regions and central administration | 40 |
| Universities, schools and research | 4 |
| Police, fire services and prisons | 2 |
- Nord-Norge44NO07
- Hovedstaden34DK01
- Trøndelag20NO06
- Oslo og Viken19NO08
- Vestlandet10NO0A
- Agder og Sør-Østlandet3NO09
- Innlandet3NO02
Table view
| Nord-Norge | 44 |
| Hovedstaden | 34 |
| Trøndelag | 20 |
| Oslo og Viken | 19 |
| Vestlandet | 10 |
| Agder og Sør-Østlandet | 3 |
| Innlandet | 3 |
- Large companies
- Medium-sized
- Small
- Micro
- SME (size not stated)
- Size not stated
Table view
| Large companies | 17 · 12.7% |
| Medium-sized | 17 · 12.7% |
| Small | 8 · 6% |
| Micro | 2 · 1.5% |
| SME (size not stated) | 35 · 26.1% |
| Size not stated | 55 · 41% |
- Denmark19
- Sweden16
- Germany2
- Finland1
- United Kingdom1
- United States1
Table view
| Denmark | 19 |
| Sweden | 16 |
| Germany | 2 |
| Finland | 1 |
| United Kingdom | 1 |
| United States | 1 |
- Under €2M turnover
- €2M–10M
- €10M–50M
- €50M and more
Table view
| Under €2M turnover | 4 · 11.8% |
| €2M–10M | 8 · 23.5% |
| €10M–50M | 15 · 44.1% |
| €50M and more | 7 · 20.6% |
- VADSØ37
- København Ø34
- Oslo20
- Trondheim14
- BERGEN8
- ALTA2
- Tromsø2
- BJUGN1
Table view
| VADSØ | 37 |
| København Ø | 34 |
| Oslo | 20 |
| Trondheim | 14 |
| BERGEN | 8 |
| ALTA | 2 |
| Tromsø | 2 |
| BJUGN | 1 |
34 of 34 winning companies registered in Norway have annual accounts in the open business registers; bands follow the EU SME turnover thresholds.
Awards to companies registered in Norway
70.1%
40 awards went to companies registered elsewhere.
Share of the 5 biggest winners
30.6%
Of all awards; a high share means a concentrated market.
Lots with a single bid
35.7%
Among 126 awards whose notice states the number of tenders.
How we count: one award per procedure, lot and winning company, from live contract award notices; a joint procurement counts on every buyer's market. Values are the awarded amounts published in the notice (framework ceilings and estimates are never added), converted to euro at the ECB yearly average. Company size is the SME flag of the notice (eForms BT-165). Read the methodology.
The same category across Europe: all 30 countries compared →
Among the companies that win most often
- Apotek 1 Gruppen AS14 public contracts in total
- Nerliens Meszansky AS25 public contracts in total
- VWR International AS26 public contracts in total
- Ortomedic AS28 public contracts in total
- Kjosavik AS (Norengros)10 public contracts in total
Where this industry meets in Norway
- NoSCoS 2027 – Congress of the Nordic Spinal Cord SocietyCongress · Oslo, Norway
- COMPAMEDTrade fair · Düsseldorf, Germany
- MEDICATrade fair · Düsseldorf, Germany
- World Health Expo Dubai (WHX, formerly Arab Health)Trade fair · Dubai, United Arab Emirates
- BULMEDICATrade fair · Sofia, Bulgaria
- HospitalarTrade fair · São Paulo, Brazil
Watch this market
One e-mail a week with the new public contract awards for pharmaceutical products in Norway: what was bought, by whom, who won. Free, no account needed.
The address is used only for this e-mail; unsubscribe with one click in any issue. Details in the privacy policy.
Which of these 57 companies could distribute your product?
A Cresques market map of Norway for this category shows the companies that win these contracts: how often, for how many buyers and for how much, and whether the leading ones are distributors or manufacturers.
Open this market map — freeFree account, no card: one market map, showing the first 5 companies with their contract awards. Paid plans show every company.
After sign-in the new-market form opens with Norway and Pharmaceutical products filled in.
No account yet? Ask for a free preview.
One page by e-mail within one working day: three distributors that already win public contracts for this kind of product in the country you choose, each one checked (is it a distributor, or a manufacturer's own sales company?), with its contract record, and the price of the full shortlist. If we can find fewer than three, the reply says so.
Read how to enter the Norway market.
Questions
- Who wins public contracts for pharmaceutical products in Norway?
- 57 companies won 63 contract award notices for these categories from 34 public buyers in Norway since November 2023. The companies that win most often are Apotek 1 Gruppen AS, Nerliens Meszansky AS, VWR International AS, Ortomedic AS, Kjosavik AS (Norengros).
- How big is the pharmaceutical products market in Norway?
- In 2025, public buyers in Norway awarded 79 supply contracts for pharmaceutical products through award notices on TED; the 37 of them that state a value (46.8%) add up to €45.9 million, a floor rather than the full contract value.
- Where do suppliers of pharmaceutical products meet buyers and distributors in Norway?
- At trade fairs and congresses such as NoSCoS 2027 – Congress of the Nordic Spinal Cord Society, COMPAMED, MEDICA, World Health Expo Dubai (WHX, formerly Arab Health), BULMEDICA, Hospitalar — each checked on the organiser's official website.
- How do I find a distributor for pharmaceutical products in Norway?
- Create a free Cresques account and open the market map for Norway and this category. It shows the companies that win public contracts there, how often, for how many buyers and for how much: the first 5 on the Free plan, every company on a paid plan. Where the data exists, the map also shows wholesalers from the business register, import figures and the industry's trade fairs.
Sources: contract award notices on TED — Tenders Electronic Daily (ted.europa.eu), © European Union, published since November 2023, processed by Cresques (one award per procedure and lot); no import figure: Eurostat's customs headings do not isolate this category.